News
Shares of Liminatus Pharma rose after the company shared plans to collaborate on developing a diagnostic kit for detecting pancreatic cancer. The stock advanced 3.7%, to $9.35, in after-hours trading ...
A compound best known for giving almonds and apricots their aroma may be the key to defeating hard-to-kill cancer cells. Japanese researchers found that benzaldehyde can stop the shape-shifting ...
The Glasgow, Scotland-based firm's Panaromic Platform uses an infrared spectroscopy-based test with machine learning-developed algorithms to detect signals of cancer.
A similarly gloomy simulation posted by Dr Paulien Moyaert back in May documented how being diagnosed with cancer can lead to ...
MRI-based screening has the potential for identifying early-stage pancreatic cancer in older adults with new onset or deteriorating diabetes, preliminary results show.
Melissa Gilbert is reflecting on the lasting impression left by Michael Landon, 34 years after his death. On Tuesday, July 1, ...
Using 400 real-world patient cases, the CARE platform correctly classified 99.5 percent of cases according to NCCN guidelines ...
During therapy, some cancer cells evolve to escape elimination. Newer anticancer drugs that can overcome this resistance are necessary. Now, researchers from Japan demonstrate that aromatic ...
During therapy, some cancer cells evolve to escape elimination. Newer anticancer drugs that can overcome this resistance are ...
Adding targeted radiation to chemotherapy prior to surgery may offer better control of pancreatic tumors—potentially reducing ...
The majority of patients with the most common advanced or metastatic cancers in the United States do not undergo ...
ImmunityBio, Inc. (NASDAQ:IBRX) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results